Skip to main content

Table 2 Diagnostic CMR results for the patients with cardiac disease subdivided according to final diagnosis (*CMR not undertaken - see Table 1)

From: Tc-HDP quantitative SPECT/CT in transthyretin cardiac amyloid and the development of a reference interval for myocardial uptake in the non-affected population

Subject

Group

CMR / Echocardiograph

P1

1

CMR: Increased LVWT basal and mid regions, normal size LV, diffusely abnormal LGE, LVEF 50%

P2

1

CMR: Concentric increased LVWT, dilated LV, diffuse abnormal myocardial LGE LVEF 23%

P3

1

CMR: Concentric increased LVWT, LV upper limit normal size, diffuse abnormal LGE, LVEF 43%

P4

1

CMR: Concentric increased LVWT, LV normal size, diffuse abnormal LGE LV and RV myocardium, LVEF 41%

P5

1

CMR: Concentric increased LVWT, LV normal size, diffuse abnormal LGE LV and RV myocardium, LVEF 60%,

P6

1

Elevated BNP, mildly elevated TnI. Stress MPS negative, LVEF low normal. No echo or CMR*

P7

2

No CMR (GFR < 30 ml/min). Echo: mild septal LVH 1.3 cm, LV dilated. LVEF 32%.

P8

3

CMR: Concentric increased LVWT, dilated LV, LVEF 29%, no significantly abnormal LGE

P9

3

CMR: Concentric increased LVWT, LV normal size, reduced LVEF 42%, no abnormal LGE

P10

3

No CMR. Echo: Concentric LVH, normal LV size, LVEF 35%,

P11

3

CMR: Concentric increased LVWT, normal LV chamber size, LVEF 51%, diffuse abnormal myocardial LGE